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Pattern Visual Evoked Potential (VEP) is Unaffected in the Early Stage of Mild 
Cognitive Impairment
(Visual Evoke Potential (VEP) Tidak Berubah dalam Peringkat Awal Kemerosotan Kognitif Ringan)
LAU CHEAN LING, NORHANI MOHIDIN, AZZATUL AINUR MOHD KAMAL, ZAINORA MOHAMMED & BARIAH MOHD-ALI
ABSTRACT
The aim of this study was to determine whether pattern-reversal Visual Evoked Potential (PRVEP) is affected in mild 
cognitive impairment (MCI). Participants aged ≥ 60 years diagnosed as MCI were invited to participate in a study together 
with a group of controls. PRVEP was measured using A RETI-port/Scan 21 and stimuli of large and small checks sizes, 
1° (60 min of arc) and 0.25° (15 min) respectively were used to obtain responses. The amplitude and implicit times of 
the MCI and control groups were then compared. A total of 18 MCI participants (age 65.7 ± 3.1 years) and 18 controls 
(65.1 ± 3.8 years) consented to participate in the study. The amplitude and implicit times for the MCI group using the 
target sizes of 60 min of arc were 9.80 ± 4.06 µV and 108.83 ± 7.63 ms and for 30 min of arc were 11.00 ± 7.44 µV 
and 123.96 ± 6.18 ms respectively. Consecutively for the control groups the amplitudes and implicit times were 8.96 ± 
3.52µV, 105.85 ± 3.60 ms and 11.97± 6.11 µV, 122.57 ± 8.28 ms. PRVEP results did not reveal significant differences in 
P100-wave amplitude nor implicit time between the two groups under investigation. This study concluded that the visual 
pathway of MCI participants may be unaffected in the early part of the disease process.
Keywords: Mild cognitive impairment (MCI); pattern-reversal visual evoked potential (PRVEP); elderly; amplitude; 
implicit times 
ABSTRAK
Tujuan kajian ini adalah untuk menentukan sama ada nilai pattern-reversal Visual Evoked Potential (PRVEP) terjejas 
dalam kemerosotan nilai kognitif ringan (MCI). Peserta berumur ≥ 60 tahun disahkan menghidap MCI telah ditawarkan 
untuk mengambil bahagian dalam kajian bersama dengan kumpulan kawalan. PRVEP diukur menggunakan A RETI-port/
Scan 21 dan rangsangan target saiz besar dan kecil, 1° (60 min arka) dan 0.25° (15 min) masing-masing telah digunakan 
untuk mendapatkan respons. Amplitud dan masa tersirat bagi MCI dari kumpulan kawalan direkod dan kemudiannya 
dibandingkan. Seramai 18 peserta MCI (min umur 65.7 ± 3.1 tahun) dan 18 kawalan (65.1 ± 3.8 tahun) bersetuju untuk 
mengambil bahagian dalam kajian ini. Amplitud dan masa tersirat kumpulan MCI menggunakan saiz sasaran 60 min 
arka adalah adalah 9.80 ± 4.06 µV dan 108.83 ± 7.63 ms masing-masing dan untuk 30 minit arka, 11.00 ± 7.44 µV dan 
123.96 ± 6.18 ms. Turutan dari itu untuk kumpulan kawalan amplitud dan masa pendam ialah 8.96 ± 3.52 µV, 105.85 
± 3.60 ms dan 11.97± 6.11 µV and 122.57 ± 8.28 ms. Keputusan PRVEP tidak menunjukkan perbezaan yang signifikan 
dalam gelombang amplitud P100 atau masa tersirat antara kedua-dua kumpulan dalam kajian. Kajian ini menyimpulkan 
bahawa laluan visual peserta MCI mungkin tidak terjejas pada awal proses penyakit ini.
Kata kunci: Kemerosotan kognitif ringan (MCI); pattern-reversal Visual Evoked Potential (PRVEP); warga tua; amplitud; 
masa pendam
INTRODUCTION
Mild cognitive impairment (MCI) is defined as a transitional 
phase between normal aging and dementia, characterized 
by subjective complaint of memory impairment but with 
normal activity of daily living functioning (Gauthier et 
al. 2006). The prevalence rate of MCI among those ≥ 65 
years of age is 12-18% (Peterson et al. 2007). In Malaysia 
a study on community based sample of urban multi-ethnic 
dwelling elderly aged ≥ 60 years from Cheras, Kuala 
Lumpur, found the prevalence rate of all-type MCI to be 
21.1% (Lee et al. 2012). Older adults with MCI represent 
a target population that is at risk of developing dementia 
particularly Alzheimer’s disease (AD), with reported 
conversion rate as high as 10-15% annually (Petersen et al. 
2001). A Korean study reported a higher rate of conversion 
at 20.1% (Kim et al. 2011). However, the possibility exists 
that individuals may remain in this stage of MCI or reverts 
to normal cognitive function (Fisk et al. 2003; Amieva et 
al. 2004). 
Visual evoked potential (VEP) is a non-invasive 
recording of electrical signals that occur in the visual 
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system in response to visual stimulation. The VEP tests 
reflect functions of the central retina and the visual 
pathway and provide important information for ocular 
disease diagnosis and treatment. VEP waveforms can be 
generated by using different visual stimuli such as line 
and checkerboard gratings. In abnormal eyes the signals 
may be smaller in size (reduce amplitudes) and may take 
longer in transmission which is reflected in the increase 
in implicit times.
Visual disturbances have been described as one of the 
initial manifestation of AD especially in the early stage of 
the disease. Symptoms include problems with reading, 
blurred vision and vague complaints of poor vision (Cronin-
Golomb et al. 1991). Mendez et al. (1990) reported that 
43% of AD participants have complex visual complaints. 
The AD participants were impaired in the visual evaluation 
of common objects, faces, spatial locations and complex 
figures. Normal routine ophthalmological examination 
results often disclosed dysfunctions of retinal ganglion 
cells as well as the optic nerve. (Danesh et al. 2006, 
Berisha et al. 2007). However other visual complaints that 
included abnormal contrast sensitivity (Rizzo et al. 1992) 
and reduced colour discrimination (Cronin-Golomb 1995) 
were not accompanied by anatomical changes usually 
seen during funduscopy, probably because the visual 
disturbances were caused by neuropathological changes in 
the visual cortex (Holory & Shepherd 2001, Pelak & Hall 
2004). These may well be the cause of visual disturbances 
in participants in the early stage of AD.
In an attempt to explain the visual symptoms of 
participants with AD, pathological and neuroimaging 
studies had been carried on the retina, optic nerve and 
visual cortex. The results of some studies suggested that 
in these participants, optic nerve degeneration and loss of 
retinal cells, specifically disappearance of ganglion cells 
and their axons was evident (Syed et al. 2005; Danesh-
Meyer et al. 2006; Berisha et al. 2007). Other studies 
suggested these visual complaints were caused by higher 
level of visual pathway changes within the visual cortex 
(Pelak & Hall 2004).
PRVEP done on participants at the early stage of AD 
showed a significant increase in implicit time of the P100 
waveform for both the large (1° 4’) and small (16’) check 
size stimulus (Krasodomska et al. 2010). However this is 
in contrast to Katz et al. (1989) and Grayson et al. (1995) 
who showed normal implicit times of the P100 in AD 
participants. Grayson et al. (1995) did not detect latency 
differences using both the flash VEP and pattern reversal 
VEP. Their results were also supported by Iseri et al. (2006) 
who also failed to show any significant differences in VEP 
P100 of their AD participants relative to control. 
The findings on effects of VEP on early AD are still 
controversial since results are contradictory. Available 
data on effects of VEP on MCI participants is scarce. Since 
MCI participants exhibit similar clinical features to early 
AD, it would be interesting to observe whether similar 
neuropathology changes is observed in the elderly MCI 
participants with or without subjective complaints of 
visual disturbances, as changes in the visual cortex could 
supersede any ocular manifestation. These changes can be 
examined by comparing the electrophysiology recordings, 
particularly PRVEP recordings of MCI participants relative 
to normal elderly participants as controls. Therefore, this 
study aims to evaluate the bioelectric function of retinal 
ganglion cells and visual pathway in MCI participants by 
means of PRVEP.
MATERIALS & METHODS
PARTICIPANTS
A total of 18 Mild Cognitive Impairment (MCI) participants 
(13 females and 5 males) aged from 60 to 72 years 
(mean age 65.7 ± 3.1) were invited to participate in the 
study. They were identified from a previous study that 
took place at the low cost housing area in Cheras Kuala 
Lumpur (Lee et al. 2012). The diagnoses were done by a 
certified psychologist as part of the Kuala Lumpur Ageing 
Study (KLAS). The diagnosis was performed through a 
multidisciplinary assessment of factors (nutrition, health, 
physical function, psychosocial) associated with cognitive 
decline and impairment through collaboration of experts 
from various agencies. The MCI participants were compared 
to a group of controls (2 females and 16 males), aged from 
60 to 71 years (mean age 65.1 ± 3.8) who met the normal 
cognitive function of Malay version of Mini-mental State 
Examination (MMSE) score of 27 and above. This Malay 
version of the MMSE has been validated among the local 
elderly population (Zarina et al. 2007).
Human ethical committee approval was obtained from 
the Medical Research and Ethics Committee of Universiti 
Kebangsaan Malaysia (UKM). The experiment protocols 
adhered to the tenets of the Declaration of Helsinki. All 
participants were briefed on the study and testing procedure 
before written consents were obtained.
PARTICIPANTS CRITERIA
The inclusion criteria for MCI participants and their age-
matched controls were: best corrected distance visual 
acuity ≥ 6/9 (Snellen) with refractive error less than ± 4.00 
DS and/or ± 2.00 DC (astigmatism), near visual acuity ≥ 
N8, absence or no previous history of any significant media 
opacities, retinal disorders and ocular pathologies. The 
exclusion criteria included having any opacity of the media 
that reduced vision worse than 6/9 (Snellen), has history of 
trauma or ocular diseases such as glaucoma and anisocoria 
greater than 2mm. With regard to systemic diseases often 
encountered in the elderly such as hypertension and 
diabetes, participants were excluded if it was more than 5 
years duration and funduscopy revealed systemic changes 
in the retina.
Chap 11.indd   90 23/01/2017   10:33:13
91
METHODS
There were three stages of this study. The first stage 
was assessment of cognitive status with MMSE for the 
controls. Normal participants who met the minimum 
score of 27 in the Malay version MMSE were accepted. 
The second stage was optometric examination to identify 
research participants. All participants chosen had to 
meet the inclusion and exclusion criteria. The last stage 
was electrophysiology tests recordings for all research 
participants done at the Clinic and Electrophysiological 
Lab, Optometry and Vision Sciences Program, Faculty of 
Health Sciences, UKM, Kuala Lumpur.
MACHINERY AND SOFTWARE SPECIFICATION
A RETI-port/Scan 21 (serial number 04-99-7003), Roland, 
Germany was used in this study. The instrument, its 
accessory and software are calibrated every 6 months 
to ensure consistency of readings. Gel-Nuprep and 
conductive paste Paste-Ten20 (D.O. Weaver & Co, USA) 
were used in preparing participants for VEP recording. The 
standard protocol for electrophysiology testing followed 
the guidelines set by the International Society for Clinical 
Electrophysiology of Vision (ISCEV). For the PRVEP test, 
stimuli of large and small checks sizes, 1° (60 min of arc) 
and 0.25° (15 min) respectively were used to obtain PRVEP 
responses, each at a rate of 3 reversals per second or a 
frequency of 1.50 Hz. 
PARTICIPANT’S PREPARATION AND TEST RECORDING 
PROCEDURES
Participant’s preparation followed ISCEV standard for VEP 
protocols. Prior to electrode placement, the skin and scalp 
were cleaned to remove oil and debris using skin prepping 
Gel-Nuprep. Conductive Paste-Ten20 was used to secure 
the electrode cup on the scalp and to help ensure good 
and stable electrical connection between the scalp and 
electrodes. For PRVEP test, electrodes used were gold disc 
electrodes (Bradenburg, Germany) of diameter 10 mm. 
Three electrodes were placed relative to bony landmarks 
on the scalp along the midline and their placements were 
in accordance to the International 10/20 system. They were 
placed at Oz (Active) over the visual cortex, Cz (Ground) 
and Fz (Reference) on the forehead. To effectively reject 
unwanted signal noise, the electrode impedances were 
maintained below 10 kΩ in all cases and were usually 
below 5 kΩ in most cases. In addition, their impedance 
differences were controlled to be less than 5 kΩ between 
electrode sites.
Recordings were performed with the pupils undilated 
and appropriate refractive error correction in relation to the 
eye-screen distance was given. A 19” CRT monitor with a 
black and white reversing checkerboard was presented 
to participants. In PRVEP test stimuli were presented 
monocularly to participants while the unstimulated eye 
was patched tightly using cotton pad securely held with 
masking tape to prevent light entering the eye. During 
recording, participants maintained fixation at a cross at the 
centre of the pattern stimulus. Throughout data recording, 
participants were advised to remain in relaxed position and 
refrain from talking to minimise muscle movements and 
other artefacts. The PRVEP was run twice and the average 
was calculated. Recordings were first done in the right eye 
followed by the left eye.
TEST PARAMETERS
For PRVEP the parameter tested included of P100 amplitude 
and implicit time (60’ arc and 15’ arc) (Figure 1) for each 
of the normal and MCI groups. Two consecutive waveforms 
were recorded in each session and the average readings 
for each parameter were used in statistical analysis. 
Manual correction to the automatic curser placement was 
performed when necessary.
FIGURE 1. A typical waveform component of the PRVEP
Time/ms
10
0
0
N75
P100
N135
100 200 300ms
-10μV
A
m
pl
itu
de
/μ
V
Chap 11.indd   91 23/01/2017   10:33:14
92
STATISTICAL ANALYSIS
PRVEP data was analysed using SPSS statistical software 
package (Version 20.0; SPSS Inc., Chicago, IL). Parameter 
results consisted of P100 amplitude and implicit times 
of the MCI and control groups. Shapiro-Wilks was used 
to test for normality of data. For normally distributed 
data (p > 0.05) parametric tests were used for statistical 
analysis. Otherwise non-parametric tests were applied to 
the same data. Since recordings were done monocularly, 
correlations between right and left eyes were done. If there 
was good correlation, reading of only one eye (RE) was 
used for further analysis. Alpha level of 0.05 will be used 
as reference and p value < 0.05 considered as statistically 
significant.
RESULTS
Thirty-six (36) participants comprising of 18 MCI and 18 
normal (control) consented to take part in the study. Shapiro-
Wilks test showed the data was normally distributed for all 
parameters (p > 0.05) therefore 2-tailed t-test was used to 
compare results of the MCI and control participants. There 
was positive correlation between the right and left eyes for 
all parameters tested (p = 0.6-0.9), therefore only the right 
eye was used for subsequent analysis.
The demography data is presented in Table 1. Amongst 
the MCI participants there were 5 males and 13 females, 
whereas in the control group there were 2 females and 16 
males. The initial results showed no significant differences 
between the MCI and control groups with respect to their age 
and visual acuity. The results also showed no significance 
differences in amplitude and implicit times of the P100 
wave component of the MCI participants compared to its 
control healthy counterparts. This is true for both the large 
(60’ arc) and small (15’ arc) check size stimuli. The results 
are summarized in Table 2.
TABLE 1. Demography of participants
   MCI Control P value
 Gender: Females 13 2 NA
  Males 5 16 NA 
 Age (Years)  65.7 ± 3.1 65.1 ± 3.8 P = 0.21
 VA  0.88 ± 0.23 1.02 ± 0.16 P = 0.91
 SE (DS)  +0.67 ± 2.27 +0.40 ± 1.75 P = 0.70
SE = spherical equivalent, VA = Visual Acuity, DS = Dioptre Sphere
The variations in amplitude and implicit times are 
displayed in Figure 2 and Figure 3. Only the results from 
the larger target (60’arc) were depicted that showed no 
definite trend or pattern in the both the MCI and control 
groups.
DISCUSSION
In an effort to find whether pattern reversal visual evoked 
potential is affected in the elderly with MCI, we measured 
the amplitude and implicit times of 18 elderly diagnosed 
with MCI and compared the results with 18 normal control. 
Our result revealed no significant differences of the 
amplitude and implicit times between the MCI and normal 
healthy participants. PRVEP represents the function of 
primary visual cortex and visual pathways. Reduced P100 
amplitude can reflect neuronal or axonal loss in the visual 
system, while an increase in latency of the P100-wave can 
reflect slowed neural conduction. This result may suggest 
intact visual pathway in this group of MCI participants. 
Sparing of the primary visual cortex in AD participants 
has also been reported in the literature. Orwin et al. (1986) 
found normal PRVEP despite increasing latency of the flash 
VEP in a 58 year-old woman with progressive AD monitored 
for three and a half years (129 ms in year 1981 to 153ms 
in year 1984). Rizzo et al. (1992) performed pattern VEP 
on 25 AD participants (mean age 64.5 ± 8.4 years) of 
various (mild to severe) stages and compared them with 
35 healthy elderly (mean age 65.1 ± 7.2 years) participants. 
He found no evidence of retino-calcarine abnormality in 
the neural visual pathways specific in AD participants. 
They concluded that the visual impairment experienced 
by some participants with AD primarily resulted from 
involvement of the visual association cortices rather than 
from pre-cortical damage, at least before the end stage of 
the disease. Philpot et al. (2002) who compared PRVEP 
of normal elderly participants and participants with mild 
TABLE 2. Amplitude and Implicit times of P100 wave component of MCI and control
       2 tailed t-test
 Parameter Eyes     MCI (N = 18)        Control (N = 18)  between MCI
       and control
   
(mean ± SD) Range (mean ± SD) Range
 P100 amplitude 60’ arc (μV) RE 9.80 ± 4.06 3.14 – 16.20 8.96 ± 3.52 2.81 – 15.55 P = 0.514
 P100 implicit time 60’ arc (ms) RE 108.83 ± 7.63 96.85 – 123.00 105.85 ± 3.60 100.10 – 112.40 p = 0.147
 P100 amplitude 15’ arc (μV) RE 11.00 ± 7.44 2.20 – 28.60 11.97 ± 6.11 2.63 – 23.64 p = 0.672
 P100 implicit time 15’ arc (ms) RE 123.96 ± 6.18 88.95 – 153.25 122.57 ± 8.28 106.00 – 133.15 p = 0.747
RE: Right eye; SD: Standard Deviation
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memory impairment not amounting to dementia observed 
the P100 component remained relatively unchanged. 
Kergoat et al. (2002) who compared individuals with 
dementia of the Alzheimer’s type (DAT) and control normal 
found no attenuation of the VEP amplitude but found a 
latency delay in VEP in DAT participants. Iseri et al. (2006) 
FIGURE 3. Variations in mean implicit times between MCI and Control groups
FIGURE 2. Variations in mean amplitude responses between MCI and Control groups
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found no abnormalities in VEP values despite significant 
reduction in parapapillary retinal nerve fibre layer (RNFL), 
macular thickness and volume in participants with AD. The 
normal VEP responses in their study suggested that primary 
cortical region and optic nerve function was normal despite 
considerable RNFL loss. However Spencer et al. (2014) 
using the electroencephalographic (EEG) component of the 
flash VEP found the latency was longer in MCI participants 
compared to controls.
Several limitations existed in this study. One of them 
was the unequal number of male and female participants 
in each group and the obvious difference in gender 
between groups. Studies have indicated that females give 
shorter implicit time measurement than male counterpart. 
However, both Guthkelch et al. (1987) and Gregori et al. 
(2006) suggested that head size and not gender play a role in 
influencing VEP readings. Guthkelch et al. (1987) observed 
the P100 implicit time to correlate highly with head size 
measurement. Studies that often found a lower implicit 
time could have consisted of more female participants, as 
it is generally known that females are of a smaller built-
size than males and have smaller head circumference 
measurement. In this study, the mean implicit time in 
the MCI group appears to be slightly higher, although not 
significant, than the control group which is dominated by 
males. It is not known if the MCI group of female dominants 
have caused attenuation of the overall P100-wave implicit 
time parameter. Future studies could take gender into 
account when measuring VEP. 
Another challenge encountered in this study was 
the much higher variation of P100-wave implicit 
time seen among the MCI participants, depicted by 
the standard deviation being as high as double that of 
control participants. Such variation could be explained 
by the inclusion of MCI participants of various levels of 
cognitive impairment. It has been reported that implicit 
time delay in VEP measurements is associated with extent 
of cognitive impairment. Most (17 out of 18) of the MCI 
participants in this study were diagnosed in a larger study 
carried out 3 years previously. It is unknown if these same 
participants are still within the early MCI range or have 
improved cognitively. Studies have shown that cognitive 
improvement can be catalysed by lifestyle changes either 
through antioxidant diet (Lee et al. 2011) or physical 
exercise (Baker et al. 2010).
Another factor that could have contributed to the 
wide variations in observed implicit times among the 
MCI participants are probably the criteria used as a cut-
off point for MCI classification. Participants recruited for 
this study was classified as MCI based on MMSE reading 
of 21 or less. Different cut-off points have been adopted 
in many studies using the MMSE since there is no clear 
cut definition of MCI. Instead of employing MMSE 21 cut-
off point as in the current study, a narrower cut-off point 
for MMSE might have been more appropriate to exclude 
probable-MCI suspects (Razali et al. 2012). Nevertheless 
this study serves to catalyse more future research in the 
area of electrophysiology among the MCI sufferers. 
All the MCI subjects in this study did not complain of 
visual problems and funduscopy did not show evidence 
of external retinal problems. The subjects also have 
normal pattern ERG but this results on pattern ERG are 
reported elsewhere. However measurements of nerve 
fibres thickness of the retina would provide additional 
data to complement the study. Future study should take 
into account of some of the limitation mentioned and the 
different stages of MCI in VEP studies among the elderly.
CONCLUSION
Within the limitation of our study it was found that there 
was no significant difference in PRVEP of MCI participants 
as compared to their control healthy counterparts. This 
may imply that in early MCI the visual pathway and visual 
cortex may be intact.
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